These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2221987)

  • 1. Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells.
    Csato M; Kenderessy AS; Judák R; Dobozy A
    Arch Dermatol Res; 1990; 282(5):348-50. PubMed ID: 2221987
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens.
    Coceani F; Bishai I; Lees J; Hynes N
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():480a-d. PubMed ID: 1825586
    [No Abstract]   [Full Text] [Related]  

  • 3. Candida albicans phagocytosis by separated human epidermal cells.
    Csató M; Bozóky B; Hunyadi J; Dobozy A
    Arch Dermatol Res; 1986; 279(2):136-9. PubMed ID: 2436583
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of Candida albicans killing activity of separated human epidermal cells by ultraviolet radiation.
    Csato M; Kenderessy AS; Dobozy A
    Br J Dermatol; 1987 Apr; 116(4):469-75. PubMed ID: 2437948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5.
    Tsai JJ; Yu LN; Wang SR
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):5-11. PubMed ID: 8216559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure.
    Lopes-Martins RA; Araújo CV; Estato V; Moreira S; Cordeiro RS; Tibiriçá EV
    Adv Exp Med Biol; 1996; 416():223-30. PubMed ID: 9131152
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection.
    Pignol B; Henane S; Pirotzky E; Mencia-Huerta JM; Braquet P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):259-65. PubMed ID: 3259039
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
    Francischi JN; Dias MF; Rocha OA; de Abreu Castro MS; Kiyomi Funayama Tatsuo MA; Farinelli P; Pacheco CM; Ferreira-Alves DL; Sirois P
    Int Arch Allergy Immunol; 1996 Apr; 109(4):398-406. PubMed ID: 8634526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
    Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436
    [No Abstract]   [Full Text] [Related]  

  • 11. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
    Pons L; Droy-Lefaix MT; Braquet P; Buéno L
    Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J; Hermán F; Braquet P
    Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro].
    Dong JC; Li M; Shi ZY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 15. Ginkgolides and platelet-activating factor binding sites.
    Hosford DJ; Domingo MT; Chabrier PE; Braquet P
    Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation.
    Kemény L; Csató M; Braquet P; Dobozy A
    Br J Dermatol; 1990 Apr; 122(4):539-44. PubMed ID: 2337521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
    Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgolides: selective acetylations, translactonization, and biological evaluation.
    Jaracz S; Strømgaard K; Nakanishi K
    J Org Chem; 2002 Jun; 67(13):4623-6. PubMed ID: 12076171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of the endotoxin-induced bronchial hyperreactivity to histamine by the platelet activating factor antagonist BN 52021.
    Nijkamp FP; Kessels GC; van Heuven-Nolsen D; Braquet P
    Pneumonol Alergol Pol; 1992; 60 Suppl 2():105-7. PubMed ID: 1305483
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of an PGF2x analogue and of some peptidoleukotrienes and platelet activating factor antagonists in experimentally induced gastric ulcer in rats.
    Nechifor M; Neughebauer IB; Costuleanu M; Alomnicăi M; Teslaru E; Filip C; Cocu F
    Rom J Physiol; 1993; 30(3-4):155-9. PubMed ID: 7582926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.